论文部分内容阅读
目的探究微创血肿清除术在神经内科的应用价值。方法 85例血肿患者,采用随机数字法分为观察组(43例)和对照组(42例),观察组采用微创血肿清除术,对照组采用传统的开颅血肿清除术进行治疗。对比两组患者治疗前后的神经功能、生存质量及两组患者的临床疗效和死亡情况。结果治疗后观察组患者的美国国立卫生研究院卒中量表(NHISS)评分明显低于对照组(P<0.05),生存质量(QOL)评分明显高于对照组(P<0.05)。观察组治疗总有效率(93.02%)高于对照组(76.19%)(P<0.05),死亡率(2.33%)低于对照组(14.29%)(P<0.05)。结论使用微创血肿清除术对血肿患者进行治疗能够有效提高治疗总有效率,改善患者的神经功能和生存质量,降低死亡率,效果显著,值得神经内科推广使用。
Objective To explore the value of minimally invasive hematoma removal in neurology. Methods 85 patients with hematoma were randomly divided into observation group (43 cases) and control group (42 cases). The observation group was treated with minimally invasive hematoma and the control group was treated by conventional craniotomy. The neurological function, quality of life and clinical efficacy and mortality of two groups were compared before and after treatment. Results After treatment, the NIHS Stroke Scale (NHISS) score of the observation group was significantly lower than that of the control group (P <0.05), and the QOL score was significantly higher than that of the control group (P <0.05). The total effective rate (93.02%) in the observation group was higher than that in the control group (76.19%) (P <0.05), and the mortality rate was 2.33% lower than that in the control group (14.29%) (P <0.05). Conclusion Minimally invasive hematoma removal of hematoma patients can effectively improve the treatment of total effective rate, improve the patient’s neurological function and quality of life, reduce mortality, the effect is significant, it is worth to promote the use of neurology.